Thomas E. Boyd
Thomas E. Boyd publishes mostly in Genetics, Oncology and Hematology, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Immunodeficiency and Autoimmune Disorders.
- World rank
- #1,040,340 of 7,710,434 ranked researchers
- Rank in United States
- #338,364 of 1,627,098
- Works
- 69
- Citations
- 3.9k
- Citations per work
- 55.9
What does Thomas E. Boyd research?
Thomas E. Boyd's work is mostly in Medicine (69%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4868.9%
- Medicine4868.9%
- Everything else1622.7%
- Life Sciences68.4%
- 1Genetics22% of their works
- 2Oncology14% of their works
- 3Hematology12% of their works
- 4Pathology and Forensic Medicine11% of their works
- 5Pulmonary and Respiratory Medicine8% of their works
- 6Immunology8% of their works
Research topics
Which keywords describe Thomas E. Boyd's research?
The keywords of their largest research topics: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Lymphoma, Genetic Mutations and Primary Immunodeficiency.
- PD-1 and PD-L1
- Targeted Therapy
- Childhood Cancer
- Imatinib
- Acute Myeloid Leukemia
- Primary Immunodeficiency
- Lymphoma
- Genomic Aberrations
- Prognostic Factors
- Rituximab
- Chronic Lymphocytic Leukemia
- Classification
- Genetic Mutations
- AML
- BCR-ABL
- Acute Lymphoblastic Leukemia
- EGFR Mutations
- Immune Checkpoint Blockade
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Rituximab622 topics
- Prognostic Factors583 topics
- Chronic Lymphocytic Leukemia391 topic
- Genomic Aberrations391 topic
- Classification231 topic
- Lymphoma231 topic
- Genetic Mutations111 topic
- Primary Immunodeficiency111 topic
- AML101 topic
- Acute Myeloid Leukemia101 topic
- BCR-ABL101 topic
- Imatinib101 topic
- Acute Lymphoblastic Leukemia91 topic
- Childhood Cancer91 topic
- EGFR Mutations81 topic
- Targeted Therapy81 topic
- Immune Checkpoint Blockade51 topic
- PD-1 and PD-L151 topic
Where does Thomas E. Boyd work?
Thomas E. Boyd's main affiliation in the publication record is Virginia Mason Memorial, United States.
How many publications and citations does Thomas E. Boyd have?
OpenAlex counts 69 works and 3,855 citations for Thomas E. Boyd, an h-index of 25, ranking #1,040,340 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Thomas E. Boyd. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.